Marina Avram

Researcher

Last publication 2026 Last refreshed 2026-05-16

unknown

3 h-index 5 pubs 10 cited

Biography and Research Information

OverviewAI-generated summary

Marina Avram's research focuses on the development and validation of analytical technologies for forensic investigations and the study of drug effects in preclinical models. Her work includes the validation of hands-free analytical urine testing technology for drug-facilitated crime investigations and the development of ToxBox kits that automate LC-MS/MS analyses to identify emerging drug threats. Avram also investigates the pharmacological effects of novel synthetic opioids and cannabinoids in mice, examining their impact on antinociception, dependence, withdrawal, and their interaction with fentanyl-induced respiratory depression. She has published four papers, with a recent publication in 2026. Avram collaborates with several researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi and Jeffery H. Moran, with whom she shares multiple publications.

Metrics

  • h-index: 3
  • Publications: 5
  • Citations: 10

Selected Publications

  • Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses (2026)
  • Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)
    3 citations DOI OpenAlex
  • Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice (2025)
    2 citations DOI OpenAlex
  • Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations (2023)
    4 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

28 Collaborators 5 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics